Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0021 Transporter Info | ||||
| Gene Name | SLC15A1 | ||||
| Transporter Name | Peptide transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefepime Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5479537 | ||||
| Docking Score | -6.85 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H24N6O5S2 | ||||
| Molecular Weight | 480.6 | ||||
| Canonical SMILES |
C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
|
||||
| InChI |
InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1
|
||||
| InChIKey | HVFLCNVBZFFHBT-ZKDACBOMSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.1 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Cefdinir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 6915944 | ||||
| Docking Score | -6.791 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C14H13N5O5S2 | ||||
| Molecular Weight | 395.4 | ||||
| Canonical SMILES |
C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\O)/C3=CSC(=N3)N)SC1)C(=O)O
|
||||
| InChI |
InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
|
||||
| InChIKey | RTXOFQZKPXMALH-GHXIOONMSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Benzylpenicillin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5904 | ||||
| Docking Score | -6.691 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H18N2O4S | ||||
| Molecular Weight | 334.4 | ||||
| Canonical SMILES |
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
|
||||
| InChI |
InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1
|
||||
| InChIKey | JGSARLDLIJGVTE-MBNYWOFBSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.8 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.